Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-09

Clinical Trial Update: Treating Severe Brain-injured Patients With Apomorphine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating apomorphine for treating disorders of consciousness in severe brain-injured patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apomorphine (apomorphine)

Snippet

Sponsor: University of Liege | Conditions: Disorder of Consciousness | Phase 2 | Status: UNKNOWN